CoagulationDisorders near Hawthorne, NY

Care Philosophy: I have always been exquisitely sensitive to the cultural and emotional aspects of being ill. Fortunately, due to innovative treatments as well as a change in the medical mindset, we are now able to approach cancer therapy with a goal of maximizing quality of life while at the same time controlling disease. In many areas of oncology, especially in advanced, difficult to treat cancers and metastatic disease, the key to pursuing therapy is individualizing treatment to the patient's personal ability to withstand therapy. Thinking of cancer as a chronic disease and gearing therapies to be sustainable and effective is among one of my most important goals as I move forward with our clinical research and cancer treatment programs.

Biography: Dr. Mundi completed his medical degree at SUNY Downstate and finished his internal medicine residency at Boston University Medical Center. He completed training in medical oncology and hematology at Columbia University Medical Center and joined the faculty in 2016. Dr. Mundi's clinical interests include bone and soft tissue sarcomas and other rare cancers, and his research interests are in adapting bioinformatics and systems biology approaches in the laboratory to guide personalized therapeutics in the clinic.

Biography: Dr. Yelena Ginzburg, MD is a Hematology Specialist who practices in New York, NY. She is 54 years old. Dr. Yelena Ginzburg, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Edward Wolin, MD is an Internist who practices in New York, NY. He is 77 years old and has been practicing for 51 years. Dr. Edward Wolin, MD is affiliated with Mount Sinai Morningside.

Biography: Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic. During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center. Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom's macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Biography: Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon's Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor.

Care Philosophy: "Better people means better experiences. Our care team is committed to delivering results that change lives."

Biography: Dr. Rajwanth Veluswamy, MD is a Hematology Specialist who practices in New York, NY. He is 45 years old. Dr. Rajwanth Veluswamy, MD is affiliated with Mount Sinai Morningside, Mount Sinai Queens and Mount Sinai Hospital.